The Centers for Disease Control and Prevention estimate that 1 in 323 infants have cerebral palsy. Highly correlated to intrauterine infection and inflammation, the incidence of cerebral palsy has remained constant over the last few decades despite significant advances in neonatal intensive care including improved ventila- 
| INTRODUCTION
Fifteen million neonates are born preterm (<37 weeks' completed gestation) around the world annually. 1, 2 Intrauterine infection remains the leading cause of spontaneous preterm birth 3, 4 despite the widespread use of intrapartum antibiotics. 5, 6 By triggering robust maternofetal proinflammatory immune responses against ensuing infection, chorioamnionitis results in early pregnancy termination to preserve the life of the mother, albeit at the expense of the developing brain and vulnerable fetus. 7, 8 Conversely, preterm birth may prevent or attenuate the development of proinflammatory fetal immune responses, thereby protecting the neonate against future adverse sequelae. The prevalence of chorioamnionitis is inversely proportional to gestational age (GA), ranging from more than 50% at 23-24 weeks' GA to 5% at term gestation (≥37 weeks' GA). 9, 10 Remarkably, microscopic examination of placental tissues demonstrates histologic indicators of chorioamnionitis in 65% of extremely preterm infants born at 23-24 weeks' GA and in one-third of neonates born at 29 weeks' GA.
11
During fetal development, the amniotic membrane safeguards the maturing fetus against exposure to pathogenic organisms, while providing an immunologically privileged site designed to protect the allogeneic fetus from maternal rejection. 10 If this membrane is breached, then chorioamnionitis may ensue. Maternal immune responses dominate the early stages of in utero infection with maternal leukocytes becoming the "first responders" that are tasked with prompt containment and elimination of the offending microorganisms. 12 If the infectious or inflammatory process continues, fetal leukocytes will subsequently infiltrate the chorionic plate and release proinflammatory cytokines and chemokines, such as interleukin (IL)-6, IL-8, and IL-18, in a condition known as fetal inflammatory response syndrome (FIRS). 8, 13, 14 Classically defined by an elevated umbilical cord plasma IL-6 concentration 8 with or without the presence of funisitis, [15] [16] [17] the severity and prevalence of FIRS increase with GA of the fetus and intensity of the initial maternal inflammatory response. 10 Recently, the cytokine IL-17A was shown to be a vital component in the initiation of FIRS and a potential contributor to the later development of chronic conditions caused by fetal exposure to in utero inflammatory and/or infectious processes. 10, 18, 19 First discovered in 1993, 20 IL-17A (aka CTLA8) belongs to a family of six IL-17 cytokines (IL-17A-F) and demonstrates diverse biologic functions. 21 30 and/or periventricular leukomalacia (PVL), which can directly injure cerebral white matter and later manifest as cerebral palsy (CP) or other forms of neurodevelopmental impairment.
31-36
Regrettably, the incidence of prematurity and CP has remained unchanged over the last few decades despite technological advances in ventilator management, widespread use of intrapartum antibiotics for the prevention of early-onset neonatal infection, intrapartum maternal steroid exposure, and surfactant administration. Presently, the administration of intrapartum magnesium sulfate for "fetal neuroprotection" to women at risk of preterm birth is the only known medical intervention that reduces the incidence of CP in surviving offspring. 51 However, the incidence of CP is significantly increased in neonates born to women with intact membranes who received magnesium sulfate in addition to prophylactic intrapartum antibiotics. 51 Likewise, neurodevelopmental outcomes are unchanged in infants following exposure to maternal magnesium sulfate who are delivered prematurely due to complications relating to chorioamnionitis.
52
This review will detail our current understanding of IL-17A and its association with common neonatal, childhood, and adult neurologic conditions. Newly discovered associations between maternal inflammatory response syndrome (MIRS) and late-onset neurologic conditions will also be highlighted. γδT lymphocytes are specialized innate immune cells that are exclusively generated before parturition and strategically located in barrier tissues, which protect the host against the outside environment. 23 IL-17A-producing γδT cells first appear within the fetal thymus around embryonic day 15 in mice, 66 but are not observed in human embryos until the 8th week of gestation. 67 In the intestinal epithelium, γδT lymphocytes increase throughout human embryonic development, while Tregs are not seen until 23 weeks' GA.
| CHORIOAMNIONITIS AND IL-17

68
In prematurely born neonates, the disproportionate quantities of γδT lymphocytes in relation to Tregs may predispose these infants to develop proinflammatory fetal conditions. Remarkably, the period between 24-28 weeks' GA in humans is generally referred to as the "window of susceptibility". 68, 69 Representing the second trimester of pregnancy, exposure to infection and/or inflammatory conditions during this critical period significantly increases the neonates' risk of developing chorioamnionitis-induced IL-17A pathology, such as sepsis, NEC, and brain injury. 69 The maturing fetal brain may be affected by IL-17A-mediated brain pathology due to impaired migration of immature post-mitotic neurons from the ventricular zone to the neocortex, leading to aberrant cortical development. 53, 70 In addition, damage to immature oligodendrocytes and microglia in white matter regions may increase the brain's susceptibility to pathologic insults during this important developmental period.
36,71-73
Tregs and Th17 cells share a common lineage regulated by the transcription factor RORγδ. 74 In preterm neonates, chorioamnionitis is associated with increased cord blood quantities of IL-17A-producing Th17 lymphocytes 75 and Tregs that exhibit Th17-like features. 23 Heightened expression of RORγδ during acute inflam- 
53,83
In summary, IL-17-mediated proinflammatory immune responses are important for clearance of extracellular pathogens.
Chorioamnionitis-mediated increases in IL-17A in fetal blood and amniotic fluid, however, are associated with cerebral white matter lesions and neurodevelopmental impairments. 32, 44, 46, 47, 84 Fetal hypoxia and ischemia, commonly associated with chorioamnionitis, enhance fetal inflammatory responses and worsen fetal white matter damage. 7, 13 This mechanism of fetal brain injury remains the leading cause of neurodevelopmental disability in prematurely born infants. 85 Remarkably, nearly one-half of all infants born before 30 weeks' GA manifest some degree of white matter injury on serial MRI. 85 Infants exposed to chorioamnionitis prior to 28 weeks' GA also experienced depressed patterns on amplitude integrated EEG (aEEG) indicating early brain injury. 86 Recent studies confirm that preterm birth alone is insufficient to cause fetal neuronal aberrations associated with neuroinflammation and white matter injury, but must occur concurrently with in utero inflammation. 71, 87 Conversely, neonates with low serum IL-17A generally demonstrate concomitant elevations of IL-10
and Th2-biased T-cell populations, promoting immune tolerance and senescence. Because immune tolerance significantly increases the incidence of neonatal bloodstream infections, these infants remain at risk of neuroinflammation, fetal brain injury, and poor neurologic outcomes. 24 
| THE ROLE OF CHORIOAMNIONITIS AND IL-17 IN CEREBRAL PALSY AND WHITE MATTER INJURY
Early associations between chorioamnionitis and CP were discovered nearly 25 years ago in a study evaluating long-term neonatal outcomes in preterm infants exposed to empiric intrapartum penicillin for preterm rupture of membranes. 88 In this study, CP was significantly reduced in the offspring of mothers randomized to the treatment group due to decreased maternal and neonatal infectious morbidities. 88 Preterm birth complicated by perinatal infection may trigger fetal proinflammatory responses that injure white matter tissues in the brain, leading to the development of cerebral palsy. Periventricular leukomalacia, a specific form of white matter injury, is the most common brain lesion in preterm infants and is often accompanied by elements of gray matter impairment.
89-91
Cerebral palsy remains the leading cause of motor disability in childhood, 92, 93 with an estimated prevalence of 1.5 to 4 per 1000 live births. 94, 95 Remarkably, the incidence of CP is significantly higher in term compared to preterm infants exposed to chorioamnionitis.
96
A recent meta-analysis confirmed a 4.7-fold increase in CP in term vs a 1.9-fold increase in CP in preterm infants following pregnancies complicated by in utero infection. 96 In murine models, intrauterine inflammation that was insufficient to induce parturition was sufficient to cause fetal brain injury in an IL-6-independent manner in both preterm and term pups. 97 Despite technological and therapeutic advances in the field of Neonatal-Perinatal Medicine that have improved patient survival at younger gestational ages, the incidence of neurodevelopmental disability, including CP, mental retardation, blindness, and/or deafness, has not declined in this patient population. 98, 99 Former preterm infants, who subsequently developed CP, exhibit Employing murine models to study the early stages of PVL revealed the proinflammatory cytokines IL-1β and TNF-α, generated during the fetal inflammatory response, mediated brain injury by increasing the permeability of the blood-brain barrier (BBB) to cytotoxic proteins. 90, 100, 104 This alteration in the BBB allows an abundance of stimulated macrophages to infiltrate inflamed brain tissue. 90 Together with elevated levels of IL-1β and TNF-α, macrophages persist in affected areas from early stages of inflammatory until the appearance of cystic cavitation late in disease pathogenesis. 90 Conversely, circumventricular portions of the brain that are devoid of the BBB allow cytokines and bacterial products from the bloodstream to directly contact cellular elements of the central nervous system (CNS Together with endothelial progenitor cells (EPCs), MSCs may have the capacity to limit inflammation-based brain injury, while facilitating neuroreparative processes (such as vascular repair) to improve neurodevelopmental outcomes. 125 More research is greatly needed to determine if similar findings will be demonstrated in human neonates.
Presently, antenatal magnesium sulfate is administered to mothers at risk of preterm delivery to reduce the risks for CP in the offspring, although its mechanism of action remains unknown. [126] [127] [128] In pregnancies complicated by preterm labor and chorioamnionitis, however, the neuroprotective effects of antenatal magnesium sulfate infusion are greatly reduced or absent. 52, 126 In neonatal murine models, magnesium sulfate decreased maternal serum levels of inflammatory markers (i.e, IL-6, INF-γ, and TNF-α) and prevented fetal neuronal damage after intrapartum systemic LPS exposure. [129] [130] [131] These findings, though, do not appear translatable to human pregnancies and immunologic differences between the two species may explain outcome differences.
Alternatively, the protective effects of magnesium sulfate may be dependent upon on the severity of fetal-maternal immune response, magnitude of intrauterine inflammation, and virulence of the causative pathogen. 97 The timing of magnesium sulfate administration may also be an important factor with irreversible neonatal brain damage occurring quickly after intrauterine inflammation/infection exposure but prior to initiation of magnesium sulfate treatment.
126,132
| FETAL ORIGINS OF CHILDHOOD AND ADULT DISEASE CAUSED BY MATERNAL INFLAMMATORY RESPONSE SYNDROME
Maternal inflammatory responses (MIRs) to in utero infection and inflammation can also increase IL-17A production by biasing naïve Th cell differentiation toward Th17 subtypes in the mother and her offspring. 122 This maternal adaption, though, can influence the risks that her offspring will develop a chronic neurologic disorder. Surprisingly, the timing and microbial source at the center of the maternal inflammatory response can impact the type of future neurologic impairment. That is, maternal infections occurring during the first or second, but not the third, trimester can increase the risk of schizophrenia.
133
Mid-gestation maternal infection generally results in suppressed exploratory behaviors, while late gestation infection usually causes perseverative behavior, such as autistic spectrum disorders (ASDs), 134 addictive behavior, and obsessive-compulsive disorder. 71, 90 In this section, neurologic conditions that originate from in utero fetal exposure to maternal inflammatory responses, but primarily present in childhood and adulthood, will be discussed including autism, schizophrenia, and multiple sclerosis (MS).
| AUTISM
An estimated 1 in 68 children residing in the United States displays behaviors consistent with ASD. 135 Although genetic and environmental factors may influence ASD risks, exposure to intrauterine inflammation may also contribute to the development of ASD. 42 Unlike previously discussed neonatal conditions, alterations within the developing fetal brain predisposing newborns to ASD appear to be caused by maternal, not fetal, inflammatory responses to in utero infection or inflammation in murine models of disease. 136 The cytokine IL-17A is implicated in ASD pathogenesis, with the gene il17a directly linked to ASD susceptibility and elevated levels of IL-17A observed in the blood of children with ASD.
136
The role of IL-17A in ASD pathogenesis was established using a murine model of MIR that induced maternal proinflammatory responses by injecting pregnant dams with polyinosinic-polycytidylic acid (poly(I:C)), a TLR3 agonist that mimics viral infection. 41 This intervention increased IL-17A levels by expanding the number of circulating maternal Th17 cells, resulting in MIR-mediated disorganized cortical phenotypes and ASD-like behaviors in the offspring. 41 These effects were dependent upon IL-17A synergy with IL-6, as IL-6-deficient mice failed to demonstrate MIR-induced ASD phenotypes. 137 To prove maternal origins of disease, these investigators deleted one or both copies of il17ra in the mother and found the offspring were rescued from MIR-induced sociability deficits. 
141,144
In humans, influenza H1N1 maternal infection during the first trimester is associated with an increased risk of schizophrenia in the offspring. 138, 145 Rat and murine models of MIR demonstrate specific alterations in brain development leading to neurodevelopmental disorders, including schizophrenia. 133 Oskvig and Colleagues 151 employing a rat model of disease discovered that neutralizing IL-6 and IL-1β prevented these alterations and inhibited MIR-induced behavioral and physiological consequences in the offspring. [151] [152] [153] Gene expression studies also demonstrated a significant downregulation of fetal genes critically important to CNS maturation and development. 151 The greatest fold reduction was observed for genes regulating neuronal migration and maturation of GABAergic interneurons. 151 Failure to demonstrate gene expression differences in the fetal brain for key mediators, such as TNF-α, IL-1β, and IL-6, between chorioamnionitis exposed and nonexposed pups lead these authors to conclude that increased serum and CSF cytokine levels were derived from maternal, not fetal, sources. Differences in animal model and gestational age for LPS-induced chorioamnionitis may explain these differences.
| MULTIPLE SCLEROSIS
Worldwide, an estimated 2.3 million people are living with multiple sclerosis and females have a higher prevalence than males. 155, 156 The diagnosis of MS is based on the distribution of inflammatory lesions throughout the CNS, which develop over time. The initial stages of MS are typically described as relapsing-remitting in nature, followed by sporadic episodes of acute neurologic dysfunction. 156 Early stages typically demonstrate full recovery in most (85%) cases. After 10-20 years, though, most patients convert to a debilitating, progressive course of MS. 156 Historically, MS was thought to be a Th1-mediated disease due to high levels of IFN-γ in MS lesions, increased serum concentrations of IL-12, and worsening of disease following IFN-γ administration.
156-158
Mice lacking critical components of the IL-12/Th1/IFN-γ pathway, however, were still susceptible to disease onset. 156, 159, 160 Involvement of IL-17A was discovered in knockout models of the p40 subunit common to IL-12 and IL-23 as these animals became resistant experi- Understanding the biology behind IL-17A and pathways involved in disease pathogenesis may facilitate the development of novel interventions and/or therapeutics, which may either prevent, cure, or alleviate neurologic symptoms often associated with these chronic, debilitating conditions.
Animal models are often utilized in the study of complex human disease, including neurologic conditions discussed in this review.
Replicating human neurologic disease in animal models remains challenging because study designs must account for variances in early brain developmental timelines when modeling fetal or progressive human brain pathologies. 174 Moreover, disparities in brain size and complexity, as well as genetic variations, between species remain compounding factors. For example, the amount of white matter in humans is roughly 4 × 10 6 mm 3 compared with 10 mm 3 in the mouse. 174, 175 Our ability to sufficiently replicate neonatal brain injury in an animal model is, therefore, a "moving target". 176 Presently, only 1 in 3 animal studies are estimated to be translatable at the level of human randomized trials and only 10% of therapeutic interventions are subsequently approved for clinical use in patients. 177 Correct identification of the timing and pathology involved in human brain injury, as well as the proper translation of medical therapies that provide more benefit than harm in an appropriately suitable animal model, continues to confound investigators. While a more precise scientific method is needed to adequately investigate human disease, the standard use of animal models remains a cornerstone of scientific investigation and provides valuable information regarding disease pathogenesis.
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